The Supreme Court Decides Mayo v. Prometheus, Strikes Down Patents
Earlier today, the Supreme Court released its decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., the latest highly anticipated installment in the Court’s grappling with biotech...
View ArticleQuick Note – The Supreme Court Has Gavrilo’d the Myriad Case
Granted, vacated, and remanded in light of . . . Prometheus. ASSN. FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, ET AL. The petition for a writ of certiorari is granted. The judgment is vacated, and the...
View ArticlePrometheus v. Mayo: Subject Matter Eligibility and Composition of Matter
The Court in Prometheus highlights that determining subject matter eligibility under section 101 is now a necessary inquiry of patentability. Some had argued that other requirements of patentability,...
View ArticleFederal Circuit Decides AMP v. Myriad (Again)
The Federal Circuit yesterday issued its opinion in AMP v. Myriad. The Supreme Court had remanded the Myriad case (GVR) in light of its decision in Prometheus v. Mayo. The Prometheus case held that a...
View ArticleAMP v. Myriad: The End of Gene Patents?
There are several notable aspects to the Federal Circuit’s recent AMP v. Myriad redecision. Of particular interest is the court’s scientific claims: that because isolated DNA and cDNA sequences are...
View ArticleAMP v. Myriad – Again!
The Court of Appeals for the Federal Circuit just decided the AMP v. Myriad case after the Supreme Court gavrilo’d (granted, vacated, and remanded) it in light of Mayo v. Prometheus. The case went back...
View ArticleACLU Files Cert Petition in Myriad Case
On Monday, the ACLU filed its petition for certiorari to the Supreme Court, challenging Myriad Genetics’ patents concerning the testing of mutations in two genes, BRCA1 and BRCA2, to diagnose several...
View ArticleAMP v. Myriad Genetics Oral Argument Recap
Today’s oral arguments in Association for Molecular Pathology v. Myriad Genetics were wide-ranging–and often-times confusing. Almost all of the Justices seemed struggled with basic principles of...
View ArticleMyriad Decision Invoked in Appeal of Suit To Invalidate Embryonic Stem Cell...
On June 13, the U.S. Supreme Court struck down patent claims of Myriad Genetics to genomic DNA in the BRCA1 and BRCA2 genes on the ground that those patents claimed mere “products of nature.” Only...
View ArticleThe World vs. Myriad(’s Patents’ Validity)
In the latest salvo in Myriad Genetic’s bloody patent disputes with its BRCA-testing competitors, Myriad has sued LabCorp after the company announced it was to begin offering its own BRCA-testing...
View Article
